Biomaterials combined with cell therapy for treatment of spinal cord injury.

Abstract:

:Spinal cord injury (SCI) is a devastating traumatic injury resulting in paralysis or sensory deficits due to tissue damage and the poor ability of axons to regenerate across the lesion. Despite extensive research, there is still no effective treatment that would restore lost function after SCI. A possible therapeutic approach would be to bridge the area of injury with a bioengineered scaffold that would create a stimulatory environment as well as provide guidance cues for the re-establishment of damaged axonal connections. Advanced scaffold design aims at the fabrication of complex materials providing the concomitant delivery of cells, neurotrophic factors or other bioactive substances to achieve a synergistic effect for treatment. This review summarizes the current utilization of scaffolding materials for SCI treatment in terms of their physicochemical properties and emphasizes their use in combination with various cell types, as well as with other combinatorial approaches promoting spinal cord repair.

journal_name

Regen Med

journal_title

Regenerative medicine

authors

Kubinová S,Syková E

doi

10.2217/rme.11.121

subject

Has Abstract

pub_date

2012-03-01 00:00:00

pages

207-24

issue

2

eissn

1746-0751

issn

1746-076X

journal_volume

7

pub_type

杂志文章,评审
  • Enhancing medial layer recellularization of tissue-engineered blood vessels using radial microchannels.

    abstract::Aim: Cell repopulation of tissue-engineered vascular grafts (TEVGs) from decellularized arterial scaffolds is limited by dense concentric tunica media layers which impede cells migrating radially between the layers. We aimed to develop and validate a new microneedle device to modify decellularized carotid arteries wit...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0011

    authors: Eufrásio-da-Silva T,Ruiz-Hernandez E,O'Dwyer J,Picazo-Frutos D,Duffy GP,Murphy BP

    更新日期:2019-11-01 00:00:00

  • The emerging landscape of reimbursement of regenerative medicine products in the UK: publications, policies and politics.

    abstract:AIM:This paper aims to map the trends and analyze key institutional dynamics that constitute the policies for reimbursement of regenerative medicine (RM), especially in the UK. MATERIALS & METHODS:Two quantitative publications studies using Google Scholar and a qualitative study based on a larger study of 43 semi-stru...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0041

    authors: Mahalatchimy A,Faulkner A

    更新日期:2017-09-01 00:00:00

  • Safety and feasibility of intramyocardial versus intracoronary delivery of autologous cell therapy in advanced heart failure: the REGENERATE-IHD pilot study.

    abstract:AIM:This study presents an interim safety and feasibility analysis of the REGENERATE-IHD randomized controlled trial, which is examining the safety and efficacy of three different delivery routes of bone marrow-derived stem cells (BMSCs) in patients with ischemic heart failure. METHODS & RESULTS:The first 58 patients ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,随机对照试验

    doi:10.2217/rme.14.3

    authors: Mozid A,Yeo C,Arnous S,Ako E,Saunders N,Locca D,Brookman P,Archbold RA,Rothman M,Mills P,Agrawal S,Martin J,Mathur A

    更新日期:2014-05-01 00:00:00

  • Gene patents, patenting life and the impact of court rulings on US stem cell patents and research.

    abstract::In June 2013, the US Supreme Court ruled that naturally occurring genes were unpatentable in the case Association for Molecular Pathology v. Myriad Genetics. Up until this decision, Myriad Genetics was the only company in the USA that could legally conduct diagnostic testing for BRCA1 and 2, genes that are linked to f...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.13.93

    authors: Matthews KR,Cuchiara ML

    更新日期:2014-03-01 00:00:00

  • First endocavitary treatment with cord blood platelet gel for perianal fistula.

    abstract::Cord blood platelet gel is prepared by activation of coagulation in a platelet concentrate obtained from cord blood. During the process of clot formation, platelet alpha-granules release growth factors that promote tissue repair. However, in the form of gel, it is not possible to inject it into small, narrow and deep ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0074

    authors: Bisceglia G,Santodirocco M,Faienza A,Mastrodonato N,Urbano F,Totaro A,Bazzocchi F,Mauro LD

    更新日期:2020-01-01 00:00:00

  • Restoration of cartilage defects using a superparamagnetic iron oxide-labeled adipose-derived mesenchymal stem cell and TGF-β3-loaded bilayer PLGA construct.

    abstract::Aim: We aimed to evaluate the capacity of the bilayer polylactic-co-glycolic acid (PLGA)/TGF-β3/adipose-derived mesenchymal stem cell (ADSC) construct used to repair cartilage defects and the role of ADSCs in the repair process in vivo. Materials & methods: Defects were created surgically on the femoropatellar groove ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0151

    authors: Yang ZG,Tang RF,Qi YY,Chen WP,Xiong Y,Wu LD

    更新日期:2020-06-01 00:00:00

  • Cell-based therapy for the treatment of female stress urinary incontinence: an early cost-effectiveness analysis.

    abstract:AIM:To perform an early cost-effectiveness analysis of in vitro expanded myoblasts (IVM) and minced myofibers versus midurethral slings (MUS) for surgical treatment of female stress urinary incontinence. METHODS:Cost-effectiveness and sensitivity analyses were performed using a decision tree comprising previously publ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0124

    authors: Vilsbøll AW,Mouritsen JM,Jensen LP,Bødker N,Holst AW,Pennisi CP,Ehlers L

    更新日期:2018-04-01 00:00:00

  • Modeling biological and economic uncertainty on cell therapy manufacturing: the choice of culture media supplementation.

    abstract:AIM:To evaluate the cost-effectiveness of autologous cell therapy manufacturing in xeno-free conditions. MATERIALS & METHODS:Published data on the isolation and expansion of mesenchymal stem/stromal cells introduced donor, multipassage and culture media variability on cell yields and process times on adherent culture ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0034

    authors: Bandeiras C,Cabral JM,Finkelstein SN,Ferreira FC

    更新日期:2018-12-01 00:00:00

  • Early evaluation and value-based pricing of regenerative medicine technologies.

    abstract::Since the first pioneering scientists explored the potential of using human cells for therapeutic purposes the branch of regenerative medicine has evolved to become a mature industry. The focus has switched from 'what can be done' to 'what can be commercialized'. Timely health economic evaluation supports successful m...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.13.69

    authors: Koerber F,Rolauffs B,Rogowski W

    更新日期:2013-11-01 00:00:00

  • Prospects of stem cell therapy in osteoarthritis.

    abstract::Osteoarthritis is a common disorder in which there is not only extensive degeneration but also an aberrant attempt at repair in joints. Stem cell therapy could provide a permanent, biological solution, with all sources of stem cells (embryonic, fetal and adult) showing some degree of potential. Mesenchymal stromal/ste...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.11.21

    authors: Roberts S,Genever P,McCaskie A,De Bari C

    更新日期:2011-05-01 00:00:00

  • Leukocyte-rich platelet-rich plasma application in post-traumatic osteoarthritis with popliteal cyst: a case report.

    abstract::Aim: To describe the successful treatment of a Baker's cyst in the setting of post-traumatic osteoarthritis using ultrasound-guided injection of platelet-rich plasma. Setting: Outpatient sports clinic. Patient: 29-year old male basketball player. Case description: The patient presented with 2-months history of right k...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2020-0021

    authors: Song B,Yeh PC,Jayaram P

    更新日期:2020-06-01 00:00:00

  • Using poly(lactide-co-glycolide) electrospun scaffolds to deliver cultured epithelial cells to the cornea.

    abstract:AIMS:To assess the potential of electrospun poly(lactide-co-glycolide) membranes to provide a biodegradable cell carrier system for limbal epithelial cells. MATERIAL & METHODS:50:50 poly(lactide-co-glycolide) scaffolds were spun, sterilized and seeded with primary rabbit limbal epithelial cells. Cells were cultured on...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.10.16

    authors: Deshpande P,McKean R,Blackwood KA,Senior RA,Ogunbanjo A,Ryan AJ,MacNeil S

    更新日期:2010-05-01 00:00:00

  • Mesenchymal stem cells for vascular regeneration.

    abstract::Mesenchymal stem cells (MSCs) have tremendous potential for regenerative medicine, and have been researched for the treatment of cardiovascular diseases. MSCs are a promising cell type because of their ease of isolation and expansion, their multipotency and their low immunogenicity. However, in order to fully utilize ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/17460751.3.6.877

    authors: Huang NF,Li S

    更新日期:2008-11-01 00:00:00

  • The use of hematopoietic stem cells in autoimmune diseases.

    abstract::Hematopoietic stem cells (HSCs) have been shown recently to hold much promise in curing autoimmune diseases. Newly diagnosed Type 1 diabetes individuals have been successfully reverted to normoglycemia by administration of autologous HSCs in association with a nonmyeloablative regimen (antithymocyte globulin + cycloph...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2015-0057

    authors: Ben Nasr M,Bassi R,Usuelli V,Valderrama-Vasquez A,Tezza S,D'Addio F,Fiorina P

    更新日期:2016-06-01 00:00:00

  • Treatment of resistant chronic central serous chorioretinopathy via platelet-rich plasma with electromagnetic stimulation.

    abstract::Background: To evaluate whether subtenon injection of platelet-rich plasma (PRP) with retinal electromagnetic stimulation (rEMS) is effective in therapy-resistant chronic central serous chorioretinopathy (CSCR). Design: Prospective, sequential. Materials & methods: The study included 22 eyes with resistant chronic CSC...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2020-0056

    authors: Arslan U,Özmert E

    更新日期:2020-08-01 00:00:00

  • The regenerative therapies of the ankle degeneration: a focus on multipotential mesenchymal stromal cells.

    abstract::The ankle degeneration ranging from focal osteochondral lesions to osteoarthritis can cause a total joint function loss. With rising life expectancy and activity of the patients, various regenerative therapies were introduced aiming to preserve the joint function via the induction of cartilage and bone repair. Here, b...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0104

    authors: El-Jawhari JJ,Brockett CL,Ktistakis I,Jones E,Giannoudis PV

    更新日期:2018-03-19 00:00:00

  • Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells.

    abstract:AIM:Dendritic cell (DC)-based vaccines have a potential utility for use in the treatment of malignancy. Human embryonic stem cells (hESCs) may provide a more cost-effective and reliable source of DCs for immunotherapy purposes, providing on-demand access for patients. METHOD:We developed a protocol to generate DCs fro...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.09.25

    authors: Tseng SY,Nishimoto KP,Silk KM,Majumdar AS,Dawes GN,Waldmann H,Fairchild PJ,Lebkowski JS,Reddy A

    更新日期:2009-07-01 00:00:00

  • The role of policies and networks in development of cord blood usage in China.

    abstract::Research regarding the use of cord blood (CB) has focused on antigen match and the number of stem cells, with policies and networks related to its use being under researched. This article is based on fieldwork in China from 2013 to 2015 and examines ways that the studied CB bank enhances CB usage in China. This articl...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0050

    authors: Chang HC

    更新日期:2017-09-01 00:00:00

  • The long and winding road that leads to a cure for epidermolysis bullosa.

    abstract::Inherited epidermolysis bullosa (EB) is a family of rare genetic skin disorders characterized by structural and mechanical fragility of skin and mucosal membranes. The main feature of EB is the presence of recurrent skin blistering or erosions, which have a profound impact in the quality of life of EB patients and, in...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.13.33

    authors: Carulli S,Contin R,De Rosa L,Pellegrini G,De Luca M

    更新日期:2013-07-01 00:00:00

  • The UK Stem Cell Bank: a UK government-funded, international resource center for stem cell research.

    abstract::The UK Stem Cell Bank is a UK Research Council-funded initiative that aims to provide ethically sourced and quality controlled stocks of cells for researchers and also establish seed stocks of cell lines for clinical trials. Whilst the Bank is prohibited from carrying out basic stem cell research (to avoid conflicts o...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.1.1.139

    authors: Stacey G,Hunt CJ

    更新日期:2006-01-01 00:00:00

  • Dimethyl sulfoxide: a central player since the dawn of cryobiology, is efficacy balanced by toxicity?

    abstract::Dimethyl sulfoxide (DMSO) is the cryoprotectant of choice for most animal cell systems since the early history of cryopreservation. It has been used for decades in many thousands of cell transplants. These treatments would not have taken place without suitable sources of DMSO that enabled stable and safe storage of bo...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0145

    authors: Awan M,Buriak I,Fleck R,Fuller B,Goltsev A,Kerby J,Lowdell M,Mericka P,Petrenko A,Petrenko Y,Rogulska O,Stolzing A,Stacey GN

    更新日期:2020-03-01 00:00:00

  • Sherley v. Sebelius.

    abstract::Following the reversal by the court of appeals of the injunction against federal funding of human embryonic stem cell research, Judge Lamberth has held such funding to be lawful and has dismissed the lawsuit. However, the litigation is likely to continue in the court of appeals and ultimately perhaps in the Supreme Co...

    journal_title:Regenerative medicine

    pub_type: 历史文章,杂志文章

    doi:10.2217/rme.11.70

    authors: Goldfarb N

    更新日期:2011-11-01 00:00:00

  • Optimizing the safety of intradiscal platelet-rich plasma: an in vitro study with Cutibacterium acnes.

    abstract::Aim: The most common risk associated with intradiscal injection of platelet-rich plasma (PRP) is discitis with Cutibacterium acnes. It is hypothesized that antimicrobial activity of PRP can be enhanced through inclusion of leukocytes or antibiotics in the injectate. Materials & methods: Multiple PRP preparations of va...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0098

    authors: Prysak MH,Lutz CG,Zukofsky TA,Katz JM,Everts PA,Lutz GE

    更新日期:2019-10-01 00:00:00

  • Conference scene. A bright future for tissue engineering and regenerative medicine in the Asia Pacific region.

    abstract::The Tissue Engineering and Regenerative Medicine International Society-Asia Pacific (TERMIS-AP) annual meeting was held in Sydney, Australia from 15-17 September 2010 and highlighted the latest developments in tissue engineering and regenerative medicine in the Asia-Pacific region. Several of the plenary lectures focu...

    journal_title:Regenerative medicine

    pub_type:

    doi:10.2217/rme.11.7

    authors: Frith JE,Hudson JE,Cooper-White JJ

    更新日期:2011-03-01 00:00:00

  • Clinical use of autologous micro-fragmented fat progressively restores pain and function in shoulder osteoarthritis.

    abstract::Aim: We aim to show that the use of nondigested micro-fragmented adipose tissue (MFat™, Lipogems®) is a viable alternative for treatment of joint pain and inflammation associated dysfunction in shoulder osteoarthritis (OA). Materials & methods: A total of 25 subjects with OA received an injection of MFat™ and were fol...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2020-0069

    authors: Vinet-Jones H,F Darr K

    更新日期:2020-10-01 00:00:00

  • Reliable assessment of bone marrow and bone marrow concentrates using automated hematology analyzer.

    abstract::Aim: A limiting factor in advancement of bone marrow based cell therapies is the lack of characterization of cell products delivered to patients. Methods: Using an automated hematology analyzer that can be implemented in clinical setting, the composition of bone marrow aspirates (n = 17 patients) and bone marrow conce...

    journal_title:Regenerative medicine

    pub_type: 临床试验,杂志文章

    doi:10.2217/rme-2018-0173

    authors: Mantripragada VP,Piuzzi NS,George J,Bova W,Ng M,Boehm C,Muschler GF

    更新日期:2019-07-01 00:00:00

  • Cardiac repair and restoration using human embryonic stem cells.

    abstract::Advances in directed differentiation of human embryonic stem cells (hESCs) toward cardiac lineages have generated much interest within the myocardial therapy field. Beyond the promise that hESCs would provide a supply of new cardiomyocytes to the damaged heart, recent studies have also shown that paracrine effects of ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.12.46

    authors: Bernstein HS

    更新日期:2012-09-01 00:00:00

  • Global update: Germany.

    abstract::Researchers are working on key issues in regenerative medicine in many of the over 280 academic institutions in Germany. Moreover, nonuniversity research institutions such as Helmholtz-, Max-Planck-, Fraunhofer- and Leibniz-Centers provide important contributions to the field of regenerative medicine in Germany. Resea...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.11.64

    authors: Lauter FR,Wirsching S

    更新日期:2011-11-01 00:00:00

  • Genzyme: 15 years of cell and gene therapy research.

    abstract::Finding solutions for patients with unmet needs is at the heart of Genzyme's innovative medical research. While small molecules and enzyme-replacement therapies have made significant strides in improving patients' quality of life and expectancy, the solutions to many conditions, such as heart disease or CNS diseases, ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.2.1.95

    authors: De Bie C

    更新日期:2007-01-01 00:00:00

  • Cell-based therapy approaches: the hope for incurable diseases.

    abstract::Cell therapies aim to repair the mechanisms underlying disease initiation and progression, achieved through trophic effect or by cell replacement. Multiple cell types can be utilized in such therapies, including stem, progenitor or primary cells. This review covers the current state of cell therapies designed for the ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.14.35

    authors: Buzhor E,Leshansky L,Blumenthal J,Barash H,Warshawsky D,Mazor Y,Shtrichman R

    更新日期:2014-01-01 00:00:00